Zogenix, Inc. (NASDAQ:ZGNX) is a pharmaceutical company engaged in discovering, developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to improve their daily functioning. We develop therapeutic treatments for rare central nervous system disorders in the United States and our company is dedicated to advancing patient care by providing early management information.
